U.S. Patent No. 12,329,781 relates to Minovia’s proprietary mitochondrial augmentation technology for the treatment of renal diseases, including renal tubulopathy, kidney insufficiency, and chronic ...

Minovia Therapeutics Ltd. ("Minovia" or the "Company"), a clinical-stage biotechnology company developing novel therapies to treat mitochondrial diseases ...

The FDA has granted an in-person Type C meeting during the first quarter of 2026 New independent analyses across large observational ALS cohorts demonstrate that modest (~10%) NfL reductions are signi ...

To help Class 9 students score high marks in the Annual Exam 2026, we have compiled complete CBSE Class 9 Study Material 2025-26 including syllabus, deleted topics, NCERT books, NCERT solutions, MCQs, ...

Artificial sweeteners, like aspartame and xylitol, offer sweetness without the calories of sugar. But are they actually ...

Nine large pharma companies have reached agreements with the Trump administration to lower certain drug prices in the U.S. Amgen, Boehringer Ingelheim, Bristol Myers Squibb, Gilead Sciences, GSK, ...

Nuvation Bio, Inc. is a biopharmaceutical company tackling some of the unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its proprietary portfolio includes six ...

) has been revised to $9.01 / share. This is a decrease of 70.88% from the prior estimate of $30.94 dated December 3, 2025. The price target is an average of many targets provided by analysts. The ...

Computational biology and bioinformatics is an interdisciplinary field that develops and applies computational methods to analyse large collections of biological data, such as genetic sequences, cell ...

Scientists are seeking permission to generate human embryonic stem cells to study disease by introducing human genetic material into an animal oocyte. This has raised ethical questions that centre on ...